Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Guardant Health, Inc.    GH

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Guardant Health, Inc.
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant360 is a molecular diagnostic test that measures 73 cancer-related genes from circulating tumor deoxyribonucleic acid (ctDNA). Its Guardant360 process includes blood collection, laboratory processing, analysis and reporting. Guardant360 is used for a range of applications, including translational science research and identifying target patient populations, drug development and commercialization post-drug approval.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Precision Oncology Testing180.4684.2%236.3282.4% +30.95%
Development Services and Other33.9115.8%50.4117.6% +48.63%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
United States194.3190.6%264.6692.3% +36.2%
International20.069.4%22.077.7% +10.02%
Managers and Directors
NameAgeSinceTitle
Helmy Eltoukhy412013Chief Executive Officer & Director
AmrAli Talasaz402013Chairman, President & Chief Operations Officer
Michael Bell502021Chief Financial Officer
Kumud Kalia-2020Chief Information Officer
Darya Chudova-2015Senior Vice President-Technology
Samir Kaul472014Independent Director
Ian T. Clark592016Lead Independent Director
Stanley J. Meresman732018Independent Director
Bahija Jallal, Dr.582019Independent Director
Vijaya Venkata Gadde462020Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 100,426,884 94,154,745 93.8% 0 0.0% 93.8%
Shareholders
NameEquities%
The Vanguard Group, Inc. 7,621,237 7.62%
SB Investment Advisers (UK) Ltd. 6,337,960 6.34%
Morgan Stanley Investment Management, Inc. 4,483,857 4.49%
Viking Global Investors LP 3,534,842 3.54%
ClearBridge Investments LLC 3,177,088 3.18%
Jennison Associates LLC 3,006,977 3.01%
Helmy Eltoukhy 2,993,538 2.99%
Khosla Ventures LLC 2,672,906 2.67%
Fidelity Management & Research Co. LLC 2,647,700 2.65%
Sequoia Capital 2,326,468 2.33%
Company contact information
Guardant Health, Inc.
505 Penobscot Drive
Redwood City, CA 94063

Phone : +1.855.698.8887
Fax : +1.888.974.4258
Web : http://www.guardanthealth.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Guardant Health, Inc.
Sector Bio Diagnostics & Testing
1st jan.Capitalization (M$)
GUARDANT HEALTH, INC.3.31%13 372
EXACT SCIENCES CORPORATION-4.47%20 464
BGI GENOMICS CO., LTD.1.61%8 196
INVITAE CORPORATION-13.87%7 082
ADAPTIVE BIOTECHNOLOGIES CORPORATION-26.13%6 081
IOVANCE BIOTHERAPEUTICS, INC.-31.53%4 670
CAREDX, INC-8.42%3 438
VERACYTE, INC.-4.15%3 143
SEEGENE INC--.--%2 920
Q-LINEA AB (PUBL)-20.00%436
BIOVICA INTERNATIONAL AB (PUBL)-29.30%121
EPIGENOMICS AG-36.03%16